Helium‐neon laser effects on conditioning‐induced oral mucositis in bone marrow transplantation patients

Cancer

Volumn 76, Issue 12, 1995, Pages 2550-2556

  Barasch, Andrei ^a   Peterson, Douglas E ^a   Tanzer, Jason M ^a   D'Ambrosio, Joseph A ^a   Nuki, Klaus ^a   Schubert, Mark M ^b   Franquin, Jean‐Claude ^c   Clive, Jonathan ^a   Tutschka, Peter ^d  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF DENTAL MEDICINE   (United States)

^b FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^c AIX MARSEILLE UNIVERSITY   (France)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

bone marrow transplantation; laser therapy; mucositis; oral

Indexed keywords

ADULT; ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HELIUM NEON LASER; HUMAN; INFECTION RISK; MALE; MUCOSA INFLAMMATION; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; DOUBLE-BLIND METHOD; FEMALE; HELIUM; HUMANS; LASERS; MALE; MIDDLE AGED; MOUTH MUCOSA; NEON; PROSPECTIVE STUDIES; STOMATITIS;

EID: 0028867546     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19951215)76:12<2550::AID-CNCR2820761222>3.0.CO;2-X     Document Type: Article

References (51)

1. Bone marrow transplant and oral complications
2. Treatment of radiation‐ and chemotherapy‐induced stomatitis
3. Pretreatment strategies for infection prevention in chemotherapy patients
4. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation
5. Oral mucositis in patients undergoing bone marrow transplantation
6. Oral mucositis after bone marrow transplantation: a marker of treatment toxicity and predictor of hepatic veno‐occlusive disease
7. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients
8. Relationships between oral mucositis and treatment variables in bone marrow transplant patients
9. Propantheline prevention of mucositis from etoposide
10. Oral complications of cancer chemotherapy: present status and future studies
11. Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteremia in allogeneic bone marrow transplant recipients
12. Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy
13. Management of orofacial pain in cancer patients
14. Clinical evaluation of MGI 209, an anesthetic, film‐forming agent for relief from painful oral ulcers associated with chemotherapy
15. Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra‐arterial chemotherapy
16. The modifying effect of beta‐carotene on radiation and chemotherapy‐induced oral mucositis
17. Vitamin E in the treatment of chemotherapy‐induced mucositis
18. Inhibition of fluorouracil‐induced stomatitis by oral cryotherapy
19. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis
20. Soft laser therapy for prevention and treatment of mucositis induced cancer chemotherapy
21. Reduction of oral toxicity of 5‐fluorouracil by allopurinol mouthwashes
22. Treatment of 5‐fluorouracil‐induced stomatitis by allopurinol mouthwashes
23. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5‐fluorouracil‐induced stomatitis
24. In vitro effect of chlorhexidine and amikacin on oral gram negative bacilli from bone marrow transplant recipients
25. Chlorhexidine for prophylaxis of infections and associated complications in bone marrow transplant patients
26. Management of mucositis during therapy
27. Effects of chlorhexidine during immunosuppressive chemotherapy
28. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse
29. The effects of sucralfate suspension and diphenhydramine syrup plus kaolin‐pectin on radiotherapy‐induced mucositis
30. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy‐induced oral mucositis
31. Cancer therapy and oral mucositis: an appraisal of drug prophylaxis
32. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive chemotherapy
33. Prostaglandin E2 for prophylaxis of oral mucositis following BMT
34. Low energy laser therapy: controversies and new research findings
35. Low level laser therapy: a review
36. Therapeutic effect of Ga‐Al‐As diode laser irradiation on experimentally induced inflammation in rats
37. Photobiology of low‐power laser effects
38. Use of carbon dioxide lasers in the complex treatment of patients with trophic ulcers and non‐healing wounds. [abstract]
39. The use of low energy laser therapy to treat aphthous ulcers
40. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation
41. Management of oral mucositis during local radiation and systemic chemotherapy: a study of 98 patients
42. Selective decontamination of the digestive tract and its role in antimicrobial prophylaxis
43. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients
44. Diagnosis, prevention, and treatment
45. Effect of helium‐neon and infrared laser irradiation on wound healing in rabbits
46. Systemic effect of low‐power laser irradiation on the peripheral and central nervous system, cutaneous wounds and burns
47. Effects of low‐energy laser on oral mucositis: a phase I/II pilot study [abstract]
48. Phase II study of He‐Ne laser prevention in BMT conditioning‐induced oral mucositis [abstract]
49. Double‐dose intensive chemotherapy with autologous marrow and peripheral blood progenitor‐cell support for metastatic breast cancer: a feasibility study
50. High‐dose thiotepa alone and in combination regimens with bone marrow support